Skip to main content
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2021 Apr 22;22(9):4366. doi: 10.3390/ijms22094366

Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639

Rebecca L Paszkiewicz 1, Richard N Bergman 1, Roberta S Santos 1, Aaron P Frank 1, Orison O Woolcott 1, Malini S Iyer 1, Darko Stefanovski 2, Deborah J Clegg 3, Morvarid Kabir 1,*
PMCID: PMC8122324  PMID: 33922401

The authors wish to make the following corrections to this paper [1]: On page 6, the curve in Figure 5a was switched with Figure 7c on Page 7. Thus, Figure 5 should be replaced with the following figure (Figure 1), and Figure 7 with the following figure (Figure 2).

Figure 1.

Figure 1

Peripheral cannabinoid receptor 1 (CB1R) antagonist increased oxygen consumption rate (OCR). 3T3-L1 adipocytes were treated with AM6545, rimonabant (RIM), and isoproterenol (ISO) at 4 and 48 h. OCR was measured in basal conditions or in response to sequential treatment with 2 oligomycin, 0.75 FFCP (respiratory chain uncoupler), and 1 µM rotenone/antimycin A (inhibitor of respiratory chain complex I and complex III) using the Seahorse XF-24 analyzer. (A) Mitochondrial respiration curves at 4 h after treatment. (B) Parameters calculated from the tracing at 4 h after treatment. (C) Mitochondrial respiration curves 48 h after treatment. (D) Parameters calculated from the OCR at 48 h after treatment. Data on graphs are presented as the mean ± standard error of mean (SEM) of 4 independent rounds of the cells; * p < 0.05 vs. control, ** p < 0.01 vs. control.

Figure 2.

Figure 2

Peripheral cannabinoid receptor 1 (CB1R) antagonist increased oxygen consumption rate (OCR) inhibited by lipolysis blocker. 3T3-L1 adipocytes were treated with AM6545 and rimonabant (RIM) with and without Atglinstatin, and isoproterenol (ISO) at 4 and 48 h. OCR was measured in basal conditions or in response to sequential treatment with 2 µM oligomycin, 0.75 µM FFCP (respiratory chain uncoupler), and 1 µM rotenone/antimycin A (inhibitor of respiratory chain complex I and complex III) using the Seahorse XF-24 analyzer. (A) Mitochondrial respiration tracing using Seahorse at 4 h after treatment. (B) Parameters calculated from the tracing at 4 h after treatment. (C) Mitochondrial respiration tracing 48 h after treatment. (D) Parameters calculated from the tracing at 48 h after treatment. Data on graphs are presented as the mean ± standard deviation (SD) of 4 independent rounds of the cells; * p < 0.05 vs. control, ** p < 0.01 vs. control.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Paszkiewicz R.L., Bergman R.N., Santos R.S., Frank A.P., Woolcott O.O., Iyer M.S., Stefanovski D., Clegg D.J., Kabir M. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020;21:6639. doi: 10.3390/ijms21186639. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES